Company news_Shanghai Liangrun Biomedical Technology Co., Ltd.

2022-01-19
This product is used for nucleic acid screening of suspected patients with 2019 novel coronavirus SA
In 2020, the Royal Swedish Academy of Sciences awarded the Nobel Prize in Chemistry to Dr. Emmanuelle Charpentier, Professor Jennifer Doudna, for their contributions to the CRISPR/Cas9 gene editing me
2021-05-08
China's vaccines are included in WHO's "emergency use list", and neutralizing an
On May 7, 2021, the World Health Organization (WHO) announced that the new crown vaccine developed by the Beijing Institute of Biological Products of China will be included in the WHO emergency use li
2021-02-19
[Government Care] Experts from Shanghai Food and Drug Administration visited Liangrun for research a
On the afternoon of February 19, 2021, Wang Anting, Director of Registration Office of Shanghai Food and Drug Administration, Wu Yi of Registration Office, Fan Zhijin, Director of Certification and Ev
2021-01-22
[Government Care] Shanghai Free Trade Zone Administration, Waigaoqiao Group Co., Ltd. and new develo
On the morning of January 21, 2021, Hu Huanzhong, deputy general manager of Shanghai Waigaoqiao Group Co., Ltd., led Cheng Wenhua, deputy director of the Economic Development Department of the Free Tr
2021-01-08
Shanghai Liangrun was awarded the title of "Specialized, Specialized and New" Enterprise i
On January 8, Shanghai Liangrun Biomedical Technology Co., Ltd. was awarded the title of Specialized, Refined, and Specialized Enterprise in Shanghai by the Shanghai Municipal Commission of Economy an

Total: 5 1 Pages：1/1

Hotline: 021-50680557

Address: 5th Floor, Building 2, No. 271, Gangao Road,
Shanghai Pilot Free Trade Zone, China